New clinical and laboratory finding in anti-phospholipid syndromes
|
Nahid Nasiri1 , Habibollah Golafshan1 , Sara Kohan Mozaffari  |
1- academic staff of shiraz medical university |
|
Abstract: (4514 Views) |
Antiphospholipid syndrome (APS) is a systemic autoimmune disease with the appearance of anti-phospholipid antibody (ACLA), Anti β2GPI and lupus anticoagulant (LAC) in serum. The antigen-antibody reaction on cell surface leads to thrombosis, miscarriage and inflammation. Clinical findings are diverse and include thrombosis in veins and arteries, pregnancy loss, thrombocytopenia, neurological and cardiac manifestation. In recent years the mechanism and pathophysiology of antiphospholipid damages has disclosed new insight to this syndrome, and better understanding and interpretation of criteria laboratory tests. |
|
Keywords: Antiphospholipid syndrome, ANTI β2GPI, pathophysiology, Antiphospholipid antibody |
|
Full-Text [PDF 530 kb]
(7391 Downloads)
|
Type of Study: Review |
Subject:
خون شناسی (هماتولوژی) Received: 2019/09/16 | Accepted: 2019/09/16 | Published: 2019/09/16
|
|
|
|
|
Add your comments about this article |
|
|